Zhang, L., Zhang, Q., Liu, J., Wu, W., Jiang, Z., Yan, B., . . . Xu, A. Immunogenicity and safety of HepE Hecolin® in chronic hepatitis B patients at clinically stable stage: An open-label study in China. Taylor & Francis Group.
Chicago Style (17th ed.) CitationZhang, Li, et al. Immunogenicity and Safety of HepE Hecolin® in Chronic Hepatitis B Patients at Clinically Stable Stage: An Open-label Study in China. Taylor & Francis Group.
MLA (9th ed.) CitationZhang, Li, et al. Immunogenicity and Safety of HepE Hecolin® in Chronic Hepatitis B Patients at Clinically Stable Stage: An Open-label Study in China. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.